NCT00200512View on ClinicalTrials.gov

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

November 30, 1999

Conditions
Parkinson Disease
Interventions
DRUG

apomorphine HCl injection

Trial Locations (2)

Unknown

Walton Centre for Neurology and Neurosurgery, Liverpool

The Morriston Hospital, Swansea

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY